Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Two-stage, Single-arm, Prospective, First-night Order Cross-over, Evaluator-blind Study to Evaluate the Efficacy, Safety and Tolerance of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea (OSA)

NCT02698059 is registered in ClinicalTrials.gov with Somnics, Inc. as lead sponsor.

NCT NCT02698059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02698059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Two-stage, Single-arm, Prospective, First-night Order Cross-over, Evaluator-blind Study to Evaluate the Efficacy, Safety and Tolerance of the iNAP® Sleep Therapy System in Adults With Obstructive Sleep Apnea (OSA)
Lead sponsor
Somnics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 22, 2016
Completion date
May 31, 2020
Enrollment
63 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea (osa)